Pharmasource Clinical Services Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-01-2025
- Paid Up Capital ₹ 0.10 M
as on 05-01-2025
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
About Pharmasource Clinical Services
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nirmala Kistipati and Sandhyarani Kantamaneni serve as directors at the Company.
- CIN/LLPIN
U73200AP2019PTC111588
- Company No.
111588
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2019
- Date of AGM
29 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pharmasource Clinical Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirmala Kistipati  | Director | 17-Jun-2022 | Current |
| Sandhyarani Kantamaneni | Director | 30-Mar-2019 | Current |
Financial Performance of Pharmasource Clinical Services.
Pharmasource Clinical Services Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pharmasource Clinical Services?
Unlock access to Pharmasource Clinical Services's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Stira Pharma Private LimitedActive 5 years 9 monthsNirmala Kistipati and Sandhyarani Kantamaneni are mutual person
- Sragvi FoundationInactive For E-Filing 4 months 22 days
Nirmala Kistipati and Sandhyarani Kantamaneni are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmasource Clinical Services?
Unlock and access historical data on people associated with Pharmasource Clinical Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmasource Clinical Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmasource Clinical Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
